IP Verse

Blood Based Biomarkers Of Tumor Sensitivity To Pd 1 Antagonists - EP3283882

PATENT ANALYSIS

Patent Details

Grant Date: Oct 16, 2024
Company: MERCK SHARP & DOHME CORP.
Oppositions

More patents of Merck Sharp & Dohme Corp.

Want to monitor this patent?

Feel free to send us a message here and we will get back to you